272 related articles for article (PubMed ID: 30925172)
1. Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.
Atkinson MA; Joo S; Sule S
PLoS One; 2019; 14(3):e0214248. PubMed ID: 30925172
[TBL] [Abstract][Full Text] [Related]
2. Cumulated organ damage is associated with arterial stiffness in women with systemic lupus erythematosus irrespective of renal function.
Sabio JM; Vargas-Hitos JA; Martínez-Bordonado J; Navarrete-Navarrete N; Díaz-Chamorro A; Olvera-Porcel C; Jiménez-Alonso J
Clin Exp Rheumatol; 2016; 34(1):53-7. PubMed ID: 26812222
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
4. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis.
Pitashny M; Schwartz N; Qing X; Hojaili B; Aranow C; Mackay M; Putterman C
Arthritis Rheum; 2007 Jun; 56(6):1894-903. PubMed ID: 17530720
[TBL] [Abstract][Full Text] [Related]
5. The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares.
Indrakanti DL; Alvarado A; Zhang X; Birmingham DJ; Hinton A; Rovin BH
Lupus; 2017 Feb; 26(2):200-203. PubMed ID: 27416847
[TBL] [Abstract][Full Text] [Related]
6. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid levels are associated with lupus nephritis in patients with normal renal function.
Calich AL; Borba EF; Ugolini-Lopes MR; da Rocha LF; Bonfá E; Fuller R
Clin Rheumatol; 2018 May; 37(5):1223-1228. PubMed ID: 29353328
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
[TBL] [Abstract][Full Text] [Related]
9. Relationship between homocysteine levels and hypertension in systemic lupus erythematosus.
Sabio JM; Vargas-Hitos JA; Martinez-Bordonado J; Navarrete-Navarrete N; Díaz-Chamorro A; Olvera-Porcel C; Zamora-Pasadas M; Jiménez-Alonso J
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1528-35. PubMed ID: 24692389
[TBL] [Abstract][Full Text] [Related]
10. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I
Front Immunol; 2020; 11():582737. PubMed ID: 33133102
[TBL] [Abstract][Full Text] [Related]
11. Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus.
Barsalou J; Bradley TJ; Tyrrell PN; Slorach C; Ng LW; Levy DM; Silverman ED
Arthritis Rheumatol; 2016 Jan; 68(1):237-46. PubMed ID: 26361097
[TBL] [Abstract][Full Text] [Related]
12. Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients.
Valero-Gonzalez S; Castejon R; Jimenez-Ortiz C; Rosado S; Tutor-Ureta P; Vargas JA; Yebra-Bango M
Scand J Rheumatol; 2014; 43(1):54-8. PubMed ID: 24050535
[TBL] [Abstract][Full Text] [Related]
13. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
[TBL] [Abstract][Full Text] [Related]
14. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
[TBL] [Abstract][Full Text] [Related]
15. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
Yuan M; Tan Y; Pang Y; Li YZ; Song Y; Yu F; Zhao MH
Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
[TBL] [Abstract][Full Text] [Related]
16. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
17. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis.
Abdel-Wahab AF; Fathy O; Al-Harizy R
Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228
[TBL] [Abstract][Full Text] [Related]
18. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
19. Male gender results in more severe lupus nephritis.
de Carvalho JF; do Nascimento AP; Testagrossa LA; Barros RT; Bonfá E
Rheumatol Int; 2010 Aug; 30(10):1311-5. PubMed ID: 19784840
[TBL] [Abstract][Full Text] [Related]
20. Long-term renal outcomes and related risk factors of familial systemic lupus erythematosus patients with lupus nephritis
.
Huang X; Tang Z; Wu X; Zhang L; Fan W; Zhang H; Hu W; Liu Z
Clin Nephrol; 2018 Oct; 90(4):262-269. PubMed ID: 29932408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
